Histamine H1 receptors in human brain labelled with [3H]doxepin - PubMed (original) (raw)

Histamine H1 receptors in human brain labelled with [3H]doxepin

S Kanba et al. Brain Res. 1984.

Abstract

Doxepin, a tricyclic antidepressant, is one of the most potent histamine H1 antagonists. Therefore, the binding of [3H]doxepin to human brain membranes was examined. Scatchard analysis revealed two distinct binding sites. The high-affinity binding site with a dissociation constant (KD +/- S.E.M.) of 3.1 +/- 0.3 X 10(-10) M was pharmacologically identified as histamine H1 receptors. Dissociation curves at low concentrations of [3H]doxepin were biphasic, suggesting several possibilities about the interaction between [3H]doxepin and histamine H1 receptors. Tetracyclic antidepressants, mianserin and maprotiline, were very potent, with KDs of 3.6 +/- 0.7 X 10(-10) M and 7.9 +/- 0.5 X 10(-10) M, respectively. Mequitazine, a new antihistamine with a weak sedative effect, had a KD of 5.8 +/- 0.8 X 10(-9), making it ten times as potent as the classic antihistamine diphenhydramine. The highest binding of [3H]doxepin to histamine H1 receptors was found in cerebral neocortex and the limbic system. The distribution of histamine H1 receptors in human central nervous system did not correlate with the previously reported distributions in rat brain and guinea pig brain determined by [3H]doxepin binding.

PubMed Disclaimer

Cited by

Histaminergic System and Vestibular Function in Normal and Pathological Conditions.
Tighilet B, Trico J, Marouane E, Zwergal A, Chabbert C. Tighilet B, et al. Curr Neuropharmacol. 2024;22(11):1826-1845. doi: 10.2174/1570159X22666240319123151. Curr Neuropharmacol. 2024. PMID: 38504566 Free PMC article. Review.
Maprotiline restores ER homeostasis and rescues neurodegeneration via Histamine Receptor H1 inhibition in retinal ganglion cells.
Chen W, Liu P, Liu D, Huang H, Feng X, Fang F, Li L, Wu J, Liu L, Solow-Cordero DE, Hu Y. Chen W, et al. Nat Commun. 2022 Nov 10;13(1):6796. doi: 10.1038/s41467-022-34682-y. Nat Commun. 2022. PMID: 36357388 Free PMC article.
Psychotropic Drugs for the Management of Chronic Pain and Itch.
Belinskaia DA, Belinskaia MA, Barygin OI, Vanchakova NP, Shestakova NN. Belinskaia DA, et al. Pharmaceuticals (Basel). 2019 Jun 24;12(2):99. doi: 10.3390/ph12020099. Pharmaceuticals (Basel). 2019. PMID: 31238561 Free PMC article. Review.
Probe dependency in the determination of ligand binding kinetics at a prototypical G protein-coupled receptor.
Bosma R, Stoddart LA, Georgi V, Bouzo-Lorenzo M, Bushby N, Inkoom L, Waring MJ, Briddon SJ, Vischer HF, Sheppard RJ, Fernández-Montalván A, Hill SJ, Leurs R. Bosma R, et al. Sci Rep. 2019 May 27;9(1):7906. doi: 10.1038/s41598-019-44025-5. Sci Rep. 2019. PMID: 31133718 Free PMC article.
A History of Drug Discovery for Treatment of Nausea and Vomiting and the Implications for Future Research.
Sanger GJ, Andrews PLR. Sanger GJ, et al. Front Pharmacol. 2018 Sep 4;9:913. doi: 10.3389/fphar.2018.00913. eCollection 2018. Front Pharmacol. 2018. PMID: 30233361 Free PMC article. Review.

Histamine H1 receptors in human brain labelled with [3H]doxepin - PubMed (original) (raw)